Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality
Nadiyah Alshehri,1,2 Anwar E Ahmed,3 Nagarajkumar Yenugadhati,2,4 Sundas Javad,2,4 Khalid Al Sulaiman,1 Hasan M Al-Dorzi,5 Majed Aljerasiy,4 Motasim Badri2,4 1Pharmaceutical Care Department, Ministry of National Guard- Health Affairs, Riyadh, Saudi Arabia; 2Department of Epidemiology & Biost...
Guardado en:
Autores principales: | Alshehri N, Ahmed AE, Yenugadhati N, Javad S, Al Sulaiman K, Al-Dorzi HM, Aljerasiy M, Badri M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b9b3d5da1f5147378d18ffc9bd0ae86f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The impact of early target attainment of vancomycin in critically ill patients with confirmed Gram-positive infection: A retrospective cohort study
por: Khalid Al Sulaiman, et al.
Publicado: (2021) -
Outcomes and Nephrotoxicity Associated with Vancomycin Treatment in Patients 80 Years and Older
por: Wang Y, et al.
Publicado: (2021) -
Diagnostic Value of Multiple Serum Biomarkers for Vancomycin-Induced Kidney Injury
por: Sang-Mi Kim, et al.
Publicado: (2021) -
Dose Optimization of Vancomycin for Critically Ill Patients Undergoing CVVH: A Prospective Population PK/PD Analysis
por: Chuhui Wang, et al.
Publicado: (2021) -
Dose Tailoring of Vancomycin Through Population Pharmacokinetic Modeling Among Surgical Patients in Pakistan
por: Muhammad Muaaz Munir, et al.
Publicado: (2021)